Amedica Names Distinguished Health Care Industry Executive Jay M. Moyes To
Board Of Directors
SALT LAKE CITY, Nov. 5, 2012
SALT LAKE CITY, Nov.5, 2012 /PRNewswire/ --Amedica Corporation, a spinal and
reconstructive medical device manufacturer, announced today that esteemed
financial executive Jay M. Moyes has been elected to its Board of Directors.
Mr. Moyes brings more than 30 years of management and leadership experience to
the Amedica Board of Directors. He has been instrumental in the financial
development and expansion of some of the medical industry's most
groundbreaking companies including Myriad Genetics, where he guided the
company through its initial public offering. Mr. Moyes currently sits on the
Board of Directors with multiple biotechnology companies including Osiris
Therapeutics Inc., Biocardia Inc., Integrated Diagnostics Inc., and Puma
Biotechnology Inc. He formerly held a Board position with the Utah Life
Science Industry Association.
"Jay brings a unique perspective to the Amedica leadership team. His
experience and insight are incredibly valued as we work to further establish
Amedica's position in the orthopedic industry," said Eric K. Olson, President
and Chief Executive Officer, Amedica. "We look forward to drawing on the
depth of his knowledge and business expertise as we expand our market
penetration and continue developing innovative products that provide both
clinical and economic value."
Throughout Mr. Moyes's career, he has worked with numerous industry-leading
companies through their transformation from emerging growth to established,
publicly-traded companies. Most recently, he served as Chief Financial
Officer at XDX, an emerging molecular diagnostics company. Previously he
served in the same role at Myriad Genetics, a publicly traded, leading
biotechnology company focused on molecular diagnostics and therapeutic
development. Prior to Myriad, Mr. Moyes served as Chief Financial Officer of
Genmark, an agricultural biotechnology company, and as a Senior Manager with
the international public accounting firm of KPMG. He holds a Masters in
Business Administration from the University of Utah and received his
undergraduate degree in economics from Weber State University.
About AMEDICA Corporation:
Amedica is an innovative spine and orthopaedic implant and device
manufacturing and distribution company that provides advanced surgical
applications including silicon nitride ceramic technologies. The company's
platform technologies represent a new standard for implants and biologics
based on superior performance, safety and efficacy. Amedica is a privately
held, private equity backed company founded in 1996 by internationally
recognized orthopaedic surgeons and ceramicists. The company is ISO 13485
certified, its spine products are FDA cleared, CE marked, and sold in ten
countries. Amedica Corporation is based in Salt Lake City, UT.
Stacey Holifield / Heather McIntyre
SOURCE Amedica Corporation
Press spacebar to pause and continue. Press esc to stop.